8-K: Pressure BioSciences Faces Filing Delays Due to Severe Weather, Moves to OTC Expert Market

Pressure BioSciences has experienced significant delays in filing its financial reports due to severe weather events in Houston, Texas, impacting its accounting firm and resulting in a temporary move to the OTC Expert Market.

Summary

• Pressure BioSciences experienced delays in filing its Annual Report on Form 10-K for the period ending December 31, 2023, and its Quarterly Report on Form 10-Q for the period ending March 31, 2024.
• These delays were caused by two independent severe weather events in Houston, Texas, where the company's independent public accounting firm is located.
• The weather events caused major disruptions to power, transportation, communications, and the ability to work.
• The Form 10-K was eventually filed on June 7, 2024.
• The company received an extension to file its Form 10-Q by July 16, 2024, from OTC Markets Group, Inc.
• A subsequent weather event further delayed the completion and filing of the Form 10-Q.
• As a result of not filing the Form 10-Q by July 16th, the company will be listed on the OTC Expert Market effective July 17th.
• The company expects to complete the independent accounting firm review and file the Form 10-Q within the next two weeks.
• Following the filing of the Form 10-Q, the company expects to be upgraded to the OTC Pink Current Information Market.
• The company intends to apply for reinstatement to the OTCQB market immediately after the upgrade to the OTC Pink Market.

Sentiment

Score: 3

Explanation: The document conveys negative sentiment due to the significant delays in financial reporting and the temporary downgrade to the OTC Expert Market. While the company expresses a commitment to transparency, the overall tone is concerning for investors.

Positives

• The company has a history of diligently completing its quarterly and annual independent accounting firm reviews and audits since its public listing in 1996.
• The company is taking steps to rectify the situation and expects to file its delayed quarterly report within the next two weeks.
• The company anticipates a quick upgrade to the OTC Pink Current Information Market after filing the delayed report.
• The company intends to apply for reinstatement to the OTCQB market, which they expect to be approved in a timely manner.

Negatives

• The company experienced significant delays in filing its annual and quarterly reports.
• The delays were caused by severe weather events, which are outside of the company's direct control.
• The company will be temporarily listed on the OTC Expert Market due to the filing delay.
• The company's reputation may be negatively impacted by the filing delays and temporary market downgrade.

Risks

• Further delays in filing the Form 10-Q could result in additional listing issues.
• The company's stock price may be negatively impacted by the temporary listing on the OTC Expert Market.
• The company's ability to raise capital may be affected by the delays and market downgrade.
• There is a risk that the reinstatement to the OTCQB market may not be approved as quickly as anticipated.

Future Outlook

The company expects to complete the independent accounting firm review and the filing of its Form 10-Q within the next two weeks, followed by an upgrade to the OTC Pink Current Information Market and an application for reinstatement to the OTCQB market.

Management Comments

• The company wishes to inform its shareholders and potential shareholders regarding the sequence of events that have resulted in undesired delays.
• We take this responsibility extremely seriously, and it is our continuous objective to maintain our listing on a stock market platform providing a high level of disclosure, transparency, and investor protection.

Industry Context

This announcement highlights the vulnerability of companies to external factors such as severe weather events, which can disrupt operations and impact financial reporting timelines. It also underscores the importance of having robust contingency plans in place.

Comparison to Industry Standards

• While weather events can impact any company, the severity of the impact on Pressure BioSciences' reporting timeline is notable.
• Many companies have backup plans for accounting and reporting in case of disruptions, and the extent of the impact on Pressure BioSciences suggests a potential weakness in their contingency planning.
• Other companies in the biotech sector, such as those listed on the NASDAQ or NYSE, typically have more robust systems in place to ensure timely financial reporting, even in the face of external disruptions.

Stakeholder Impact

• Shareholders will be negatively impacted by the temporary listing on the OTC Expert Market and the potential for a decrease in stock price.
• The company's reputation may be negatively impacted, which could affect future business opportunities.
• Employees may be concerned about the company's financial stability and future prospects.

Next Steps

• The company will complete the independent accounting firm review and file the Form 10-Q within the next two weeks.
• The company will be upgraded to the OTC Pink Current Information Market immediately after filing the Form 10-Q.
• The company intends to apply for reinstatement to the OTCQB market.

Key Dates

Keywords

filing delays, OTC Expert Market, OTC Pink Market, OTCQB, weather events, financial reports, Form 10-K, Form 10-Q, accounting firm, market listing